Ken Fisher Vanda Pharmaceuticals Inc. Transaction History

Fisher Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 12, 2023	BUY	$5.9 - $6.95 $795,272 - $936,804	134,792 New	134,792 $888,000
Q2 2023 Aug 08, 2023	SELL	$5.9 - $6.95 $3,422 - $4,031	-580 Reduced 0.43%	134,792 $888,000
Q1 2023 Dec 12, 2023	BUY	$6.18 - $7.99 $833,014 - $1.08 Million	134,792 New	134,792 $915,000
Q1 2023 May 01, 2023	BUY	$6.18 - $7.99 $3,584 - $4,634	580 Added 0.43%	135,372 $919,000
Q4 2022 Feb 03, 2023	BUY	$6.87 - $10.96 $220,774 - $352,210	32,136 Added 31.3%	134,792 $996,000
Q3 2022 Nov 08, 2022	BUY	$9.44 - $11.76 $312,161 - $388,879	33,068 Added 47.52%	102,656 $1.01 Million
Q1 2022 May 05, 2022	BUY	$10.84 - $16.55 $322,880 - $492,958	29,786 Added 74.84%	69,588 $787,000
Q4 2021 Feb 02, 2022	BUY	$15.69 - $21.14 $624,493 - $841,414	39,802 New	39,802 $624,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.